Moss Medicines: The Next Revolution in Biotech?
Plant biotechnologists are favoring moss factories over other models to produce certain valuable proteins.
Summary
Plant biotechnologists are increasingly turning to mosses as protein production platforms. Unlike bacteria or mammalian cells, mosses offer eukaryotic protein production, leading to more accurate protein folding and post-translational modifications. Compared to other plant-based systems like tobacco or algae, mosses boast simpler genetic makeup, facilitating easier manipulation and higher protein yields. They also grow rapidly, are inexpensive to cultivate in bioreactors, and present lower risks of contamination due to the lack of human pathogens. This combination of factors makes moss “factories” a promising and efficient alternative for producing valuable therapeutic and industrial proteins.
Read more…
This post is part of “Science and Technology News”, Follow for more…!!!
Credits: Source
Disclaimer
Discover more from abdullahfarhan.com
Subscribe to get the latest posts sent to your email.